相似文献
1
Antigen binding and capping by lymphocytes of genetic nonresponder mice.
J Exp Med. 1972 Aug 1;136(2):403-8. doi: 10.1084/jem.136.2.403.
2
Blocking and redistribution ("capping") of antigen receptors on T and B lymphocytes by anti-immunoglobulin antibody.
J Exp Med. 1973 Apr 1;137(4):1060-77. doi: 10.1084/jem.137.4.1060.
3
4
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) II. Cellular source and effect on responder and nonresponder mice.
J Exp Med. 1977 Apr 1;145(4):828-38. doi: 10.1084/jem.145.4.828.
5
Genetic control of the immune response. Frequency and characteristics of antigen-binding cells in high and low responder mice.
J Exp Med. 1973 May 1;137(5):1180-200. doi: 10.1084/jem.137.5.1180.
6
Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice.
J Exp Med. 1974 Jul 1;140(1):172-84. doi: 10.1084/jem.140.1.172.
7
Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter.
Proc Natl Acad Sci U S A. 1972 Jul;69(7):1934-8. doi: 10.1073/pnas.69.7.1934.
8
Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
J Exp Med. 1973 Nov 1;138(5):1121-32. doi: 10.1084/jem.138.5.1121.
9
Antigen-binding cells. I. Their idenification and role in the immune response.
J Immunol. 1971 Oct;107(4):1168-74.
10
Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
J Exp Med. 1973 Nov 1;138(5):1107-20. doi: 10.1084/jem.138.5.1107.
引用本文的文献
1
Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice.
J Exp Med. 1974 Jul 1;140(1):172-84. doi: 10.1084/jem.140.1.172.
2
Ligand-induced redistribution of membrane macromolecules: some possible implications for cancer.
J Clin Pathol Suppl (R Coll Pathol). 1974;7:31-4.
3
Events after the binding of antigen to lymphocytes: removal and regeneration of the antigen receptor.
J Exp Med. 1974 May 1;139(5):1110-24. doi: 10.1084/jem.139.5.1110.
4
Monospecificity of bone marrow-derived lymphocytes.
J Exp Med. 1973 Apr 1;137(4):1024-30. doi: 10.1084/jem.137.4.1024.
5
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice.
J Exp Med. 1974 Jul 1;140(1):199-217. doi: 10.1084/jem.140.1.199.
6
Ligand-induced movement of lymphocyte membrane macromolecules. 3. Relationship between the formation and fate of anti-Ig-surface Ig complexes and cell metabolism.
J Exp Med. 1973 Mar 1;137(3):675-89. doi: 10.1084/jem.137.3.675.
7
Function of macrophages in antigen recognition by guinea pig T lymphocytes. II. Role of the macrophage in the regulation of genetic control of the immune response.
J Exp Med. 1973 Nov 1;138(5):1213-29. doi: 10.1084/jem.138.5.1213.
8
Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
J Exp Med. 1973 Nov 1;138(5):1121-32. doi: 10.1084/jem.138.5.1121.
9
Genetic control of immune responses in vitro. I. Development of primary and secondary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro.
J Exp Med. 1973 Nov 1;138(5):1107-20. doi: 10.1084/jem.138.5.1107.
10
Genetic control of the immune response. Frequency and characteristics of antigen-binding cells in high and low responder mice.
J Exp Med. 1973 May 1;137(5):1180-200. doi: 10.1084/jem.137.5.1180.
本文引用的文献
1
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
2
The behavior of hapten-poly-L-lysine conjugates as complete antigens in genetic responder and as haptens in nonresponder guinea pigs.
J Exp Med. 1966 May 1;123(5):859-79. doi: 10.1084/jem.123.5.859.
3
Antigenicity of polypeptides (poly alpha amino acids). XV. Studies on the immunogenicity of synthetic polypeptides in mice.
J Exp Med. 1965 Oct 1;122(4):665-71. doi: 10.1084/jem.122.4.665.
4
Antigen binding cells in tolerance and immunity.
Transplant Rev. 1970;5:105-29. doi: 10.1111/j.1600-065x.1970.tb00358.x.
5
Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs.
J Exp Med. 1971 Aug 1;134(2):495-516. doi: 10.1084/jem.134.2.495.
6
Immunoglobulin spots on the surface of rabbit lymphocytes.
J Exp Med. 1970 Nov;132(5):1001-18. doi: 10.1084/jem.132.5.1001.
7
8
9
Histocompatibility-linked immune response genes.
Science. 1972 Jan 21;175(4019):273-9. doi: 10.1126/science.175.4019.273.
10
Antigen-binding cells. I. Their idenification and role in the immune response.
J Immunol. 1971 Oct;107(4):1168-74.
Zotero 插件